“Invitro” plans to launch a program for the diagnosis of coronavirus

The or medical company “Invitro” has announced that it plans next month to launch a program of testing for the presence of coronavirus infection. Studies are not free, the cost of services is not yet known, however, to results patients two days after testing.

Currently, a private company engaged in the acquisition of special test systems and developing the required TECHNOBASE. Start taking the tests at all interested “in vitro” plans within the next month. A company representative said that to ensure the safety of citizens and prevent the spread of the virus in one area will not accept more than three patients. The results of the research will be issued to customers within two days.

It is noted that the presence of the virus
will be determined by polymerase chain reaction — spectest that
was created by the ad hoc Committee management birikimi health the Ministry of health.